mesalamine has been researched along with Granuloma, Giant Cell in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Granuloma, Giant Cell: A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva (giant cell epulis); central refers to the jaw.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogenrieder, T | 1 |
| Rogler, G | 1 |
| Vogt, T | 1 |
| Landthaler, M | 1 |
| Stolz, W | 1 |
1 review available for mesalamine and Granuloma, Giant Cell
| Article | Year |
|---|---|
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Diagnosis, Differential; Granulo | 2003 |